Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

News

Fish Oil for People with High Alzheimer’s Risk

August 6, 2024 No Comments

Older adults with a genetic predisposition to Alzheimer’s disease may benefit from fish oil supplements.

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

July 26, 2024 No Comments

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

Weight-loss Drug Ozempic Cuts Dementia Risk 48%

July 21, 2024 No Comments

University of Oxford research revealed groundbreaking findings that could reshape dementia prevention. Ozempic (AKA Semaglutide/Wegovy), a type-2 diabetes and weight-loss drug, seems to significantly reduce the risk of dementia.

How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs

July 14, 2024 3 Comments

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

July 5, 2024 No Comments

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

June 26, 2024 1 Comment

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Person Encircling the Date on the Calendar

Making it Easier to Take Leqembi for Alzheimer’s

June 23, 2024 1 Comment

A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Bigger is Better: Brain Size Up 7%, Dementia Down 25%

May 28, 2024 1 Comment

In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.

Caregivers Delight: 31-Day Pill Organizer, 4 Times a Day

September 2, 2025

PRODUCT OF THE WEEK: Caregivers love this pill box, as do patients and professionals. Simply fill it once a month. Roomy, simple, ingenious.

Dear God, Be good to me. The sea is so wide, And my boat is so small.

Thought of the Week: The Sea is So Wide

September 2, 2025

New Weekly Alzheimer’s Injection Brings Care Home

September 2, 2025

Caring for someone with Alzheimer’s is demanding enough. Now, instead of traveling for hours of infusions, families can turn to Leqembi IQLIK—a once-weekly injection approved by the FDA that makes treatment simpler, safer, and closer to home.

Most Popular Stories

How Do You Know If Someone Has Alzheimer’s?

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

kid, coffee, cup, breakfast, tiny, kids, small, coffee, coffee, coffee, coffee, coffee, kids

Big Cup, Little Man: Picking Up the Earliest Signs of Alzheimer’s

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?